Skip to main content

Transcript: Impact of Cochrane evidence on tranexamic acid for acute traumatic injury

Tranexamic Acid: a low-cost, life-saving drug

Cochrane health evidence: Making a difference

[Each year 600,000 patients bleed to death worldwide]

Ian Roberts, Cochrane review author, Cochrane Injuries: "Traumatic injury is a leading cause of death worldwide. Many patients with traumatic injury actually bleed to death."

[The Cochrane Injuries Group showed there is a 10% reduction in death when patients are given tranexamic acid]

[Tranexamic Acid (TXA) is a drug prescribed over the counter for heavy menstrual bleeding and used in hospitals for orthopaedic surgery]

"What we found is that it reduces the risk of bleeding to death with no risk in the increase of thrombosis, so it's a tremendous result."

[Widespread use of TXA could save 128,000 lives each year]

"We didn't find any evidence of side effects. So, if you have a drug that helps clotting, you're obviously worried that it's going to cause clots where you don't want them, so causing thrombosis. To treat one bleeding patient would cost about £3. Now that reduces their risk of bleeding to death by one-sixth. There are very few cheaper ways to save a life than this."

[Based on results from this Cochrane review, the British military began to use TXA. TXA is now used by the United States, NATO and other armed forces around the world.]

[Many national ambulance services now use TXA. It has been added to the WHO essential medicines list.]

Our use of cookies

We use necessary cookies to make our site work. We'd also like to set optional analytics cookies to help us improve it. We won't set optional cookies unless you enable them. Using this tool will set a cookie on your device to remember your preferences. You can always change your cookie preferences at any time by clicking on the 'Cookies settings' link in the footer of every page.
For more detailed information about the cookies we use, see our Cookies page.

Accept all
முறைப்படுத்து